Upload
bennett-norman
View
225
Download
0
Embed Size (px)
Citation preview
Office of Overseas Programming & Training Support (OPATS)
Treatment AdherenceHIV Care, Support, and Treatment
Antiretroviral Therapy (ART)
ART dramatically improves the quality of life of PLHIV and restores hope–Patients gain weight, are less fatigued,
feel better, are often able to return to work–Slows or stops progression of illness
Joseph Jeune, a farmer in Haiti, before and after treatment for HIV/AIDS and TB co-infection
Access to ART
While access to HIV treatment has increased by 63 percent from 2009 to 2011, only 54 percent of people eligible for HIV treatment in low and middle-income countries were on ART in 2012
Care and Treatmentin the pre-ART Period Critical to identify HIV-infected persons early
and enroll in care and support services After diagnosis, but before ART, regular clinic
visits and care and support services are vital– For clinic checkups (prophylaxis, screening,
treatment for OIs, to monitor progression, etc.)– For education in self-care and living positively to
stay healthy and maintain strong immune system– To meet psychosocial needs (support groups, etc.)
Eligibility for ART
Prompt and timely initiation of ART results improved quality of life and reduced mortality
Eligibility for ART is determined at the clinic – When CD4 thresholds are reached (and other
criteria) – And before OIs contribute to poor outcomes
CD4 Count
The major lab indicator of immune function in PLWHIV
Key factor in determining:– Urgency of antiretroviral therapy (ART) initiation– Need for prophylaxis for opportunistic infections
Strongest predictor of subsequent disease progression and survival
Clinical Exams for ART Eligibility
Medical history Physical exam: WHO clinical
staging and disease classification Laboratory tests: CD4 count, Viral
load, OI screening (including TB)
Country-specific ART Eligibility Criteria: South Africa Example Adults: CD4 count <350 cells/mm OR clinical
staging 3 and 4 (WHO) OR patient with TB Infants and children: All children under 5,
irrespective of CD4 cell count Fast tracking ART initiation: Children under 1,
CD4 cell count <200 cells/mm, clinical staging 4, women who are pregnant or breastfeeding, patients with TB and CD4 cell count <50 cells/mm
ART: How It Works
ART uses a combination of at least three ARVs– This combination suppresses the HIV virus and
stops the virus from multiplying– With less virus, the immune system becomes
stronger, resists infections, and the person gets sick less often
NOTE: ART does not completely destroy the virus or cure the disease and ART can reduce, but not eliminate the risk of HIV transmission. People on ART can still transmit the virus to others.
ARV Drugs
The combination of three drugs reduces the likelihood of the virus developing resistance
First, second, and third-line therapies are different combinations of ARV drugs– First-line: Usually standard, but doctor may adjust if
patient is pregnant or if person has TB– Second-line: Prescribed if first-line does not work or if
there are side effects– Third-line: National guidelines, based on funding,
sustainability, and ART access
Successful Treatment with ARVs
Must be taken daily for remainder of patient’s life to continually suppress the virus– Must be taken at specific times of day, under
specific conditions– Must be carefully stored– Must take 95 percent or higher of scheduled doses– Most effective when patients are well-nourished
If ARVs are NOT taken correctly, benefits are rapidly reversed, virus may become resistant
Predicted and observed risk of viral control according to the longer interval of treatment discontinuation,
POSOVIR and REACH cohorts
Side Effects of ARVs
All medicines can cause side effects, including ARVs. Most common with ARV:– Headaches, nausea, diarrhea, skin rashes, tingling
sensations, tiredness, nightmares or anxiety, and changes in body
Vary in severity (minor/major), duration, and start; some manageable by patient
Can interfere with treatment adherence, lessen quality of life, or cause long-term health conditions
ART and TB Treatment
PLHIV more susceptible to TB; TB most common cause of death of PLHIV
A doctor must decide how to treat both diseases in people with both TB and HIV
Some ARVs cannot be used at the same time as some TB drugs; thus, a doctor will prescribe a special first-line ARV drug combination for patients with TB
Treatment Adherence
The ability to start, manage, and maintain a given medication regimen at the times, frequencies, and under specific conditions as prescribed by a health care provider
MORE than just taking drugs– Patient attends all scheduled clinical care visits,
follow-up appointments and monitoring, lab tests– Patient practices recommended behaviors (diet,
limiting use of alcohol)
The Importance of Treatment Adherence Suboptimal adherence– Treatment failure– Limited future treatment options (second-
line therapy much more expensive, often unavailable)– Increased risk of HIV transmission to others– Increased mortality
Care and Support is Vital for Treatment Adherence
ART Initiation and Patient Readiness ART initiation involves a partnership
between PLHIV and the health system–Critical to involve patient in decision–Requires adequate preparation and
support–Requires commitment from patient
Patient Preparation for ART
Counseling– To identify barriers and solutions
Training– Treatment literacy
Patient Assessment – Beliefs, attitudes, mental health
Identification of social support– Help with disclosure, socioeconomic situation
Development of a treatment plan
Barriers to Treatment Adherence
Individual FactorsSystem FactorsCommunity FactorsMedication Factors
Despite Barriers, Treatment Adherence Can Be Achieved Adherence is feasible in low-resource settings– 77 percent of patients in Africa achieved adequate
treatment adherence (defined as taking 95 percent of prescribed pills) compared with just 55 percent in North American settings
Good adherence has been shown within key populations, including sex workers and People Who Inject Drugs